澳大利亚丙型肝炎监测策略头两年的结果。

Jenean Spencer, Gregory Dore, Monica Robotin, Patty Correll, John Kaldor
{"title":"澳大利亚丙型肝炎监测策略头两年的结果。","authors":"Jenean Spencer, Gregory Dore, Monica Robotin, Patty Correll, John Kaldor","doi":"10.33321/cdi.2002.26.3","DOIUrl":null,"url":null,"abstract":"<p><p>The objectives of national hepatitis C surveillance are to identify those at risk in order to appropriately target prevention and care programs, and to evaluate the impact of these approaches. In 1998 the Communicable Diseases Network Australia New Zealand (CDNANZ) appointed the Hepatitis C Surveillance Committee to develop and implement approaches for improved hepatitis C surveillance in Australia. The Australian Hepatitis C Surveillance Strategy was endorsed in 1999 and provides a framework for improvements to national hepatitis C surveillance. The strategy covers two main surveillance activities: surveillance of incident and prevalent hepatitis C, and the long-term outcomes of hepatitis C. The committee (now the CDNA Viral Hepatitis Surveillance Committee) has continued to facilitate the implementation of the recommendations proposed. Progress towards improvement of hepatitis C surveillance in Australia includes the development of standard case reporting for hepatitis C, collation of data on incident and prevalent hepatitis C from a range of populations at lower and higher risk of hepatitis C, and collation of data from liver transplant registries. Advances in the implementation of the strategy are incremental. While there is enthusiastic commitment towards improving hepatitis C surveillance in Australia, the number of cases, the capacity and competing priorities of State and Territory health departments has meant that implementation has been challenging, highlighting the difficulties in introducing new systems into an already complex situation.</p>","PeriodicalId":520897,"journal":{"name":"Communicable diseases intelligence quarterly report","volume":"26 1","pages":"14-22"},"PeriodicalIF":0.0000,"publicationDate":"2002-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Outcomes from the first two years of the Australian hepatitis C surveillance strategy.\",\"authors\":\"Jenean Spencer, Gregory Dore, Monica Robotin, Patty Correll, John Kaldor\",\"doi\":\"10.33321/cdi.2002.26.3\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>The objectives of national hepatitis C surveillance are to identify those at risk in order to appropriately target prevention and care programs, and to evaluate the impact of these approaches. In 1998 the Communicable Diseases Network Australia New Zealand (CDNANZ) appointed the Hepatitis C Surveillance Committee to develop and implement approaches for improved hepatitis C surveillance in Australia. The Australian Hepatitis C Surveillance Strategy was endorsed in 1999 and provides a framework for improvements to national hepatitis C surveillance. The strategy covers two main surveillance activities: surveillance of incident and prevalent hepatitis C, and the long-term outcomes of hepatitis C. The committee (now the CDNA Viral Hepatitis Surveillance Committee) has continued to facilitate the implementation of the recommendations proposed. Progress towards improvement of hepatitis C surveillance in Australia includes the development of standard case reporting for hepatitis C, collation of data on incident and prevalent hepatitis C from a range of populations at lower and higher risk of hepatitis C, and collation of data from liver transplant registries. Advances in the implementation of the strategy are incremental. While there is enthusiastic commitment towards improving hepatitis C surveillance in Australia, the number of cases, the capacity and competing priorities of State and Territory health departments has meant that implementation has been challenging, highlighting the difficulties in introducing new systems into an already complex situation.</p>\",\"PeriodicalId\":520897,\"journal\":{\"name\":\"Communicable diseases intelligence quarterly report\",\"volume\":\"26 1\",\"pages\":\"14-22\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2002-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Communicable diseases intelligence quarterly report\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.33321/cdi.2002.26.3\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Communicable diseases intelligence quarterly report","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.33321/cdi.2002.26.3","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

摘要

国家丙型肝炎监测的目标是确定高危人群,以便适当地针对预防和护理规划,并评估这些方法的影响。1998年,澳大利亚和新西兰传染病网任命了丙型肝炎监测委员会,负责制定和实施改进澳大利亚丙型肝炎监测的办法。澳大利亚丙型肝炎监测战略于1999年获得批准,为改进全国丙型肝炎监测提供了一个框架。该战略包括两项主要监测活动:监测丙型肝炎事件和流行情况,以及丙型肝炎的长期结果。委员会(现为CDNA病毒性肝炎监测委员会)继续促进所提出建议的实施。澳大利亚在改善丙型肝炎监测方面取得的进展包括制定丙型肝炎标准病例报告,整理一系列丙型肝炎低风险和高风险人群的发病率和流行丙型肝炎数据,以及整理肝移植登记处的数据。在实施该战略方面取得的进展是渐进的。虽然澳大利亚积极致力于改善丙型肝炎监测,但病例数量、能力和州和地区卫生部门的竞争优先事项意味着实施工作具有挑战性,突出了在已经复杂的情况下引入新系统的困难。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Outcomes from the first two years of the Australian hepatitis C surveillance strategy.

The objectives of national hepatitis C surveillance are to identify those at risk in order to appropriately target prevention and care programs, and to evaluate the impact of these approaches. In 1998 the Communicable Diseases Network Australia New Zealand (CDNANZ) appointed the Hepatitis C Surveillance Committee to develop and implement approaches for improved hepatitis C surveillance in Australia. The Australian Hepatitis C Surveillance Strategy was endorsed in 1999 and provides a framework for improvements to national hepatitis C surveillance. The strategy covers two main surveillance activities: surveillance of incident and prevalent hepatitis C, and the long-term outcomes of hepatitis C. The committee (now the CDNA Viral Hepatitis Surveillance Committee) has continued to facilitate the implementation of the recommendations proposed. Progress towards improvement of hepatitis C surveillance in Australia includes the development of standard case reporting for hepatitis C, collation of data on incident and prevalent hepatitis C from a range of populations at lower and higher risk of hepatitis C, and collation of data from liver transplant registries. Advances in the implementation of the strategy are incremental. While there is enthusiastic commitment towards improving hepatitis C surveillance in Australia, the number of cases, the capacity and competing priorities of State and Territory health departments has meant that implementation has been challenging, highlighting the difficulties in introducing new systems into an already complex situation.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信